Development of pH-sensitive pectinate/alginate microspheres for colon drug delivery



The purposes of this study were to develop and evaluate calcium pectinate/alginate microspheres (PAMs) and to exploit their pH-sensitive properties for colon-targeted delivery of encapsulated cisplatin. PAMs were prepared using an electrospraying method. The PAMs, as cores, were then coated with Eudragit S100 using a polyelectrolyte multilayer coating technique in aqueous solution. The morphology of the microspheres was observed under scanning electron microscopy. In vitro drug release studies were performed in simulated gastrointestinal fluid, and the results indicated that approximately 5 % of the cisplatin was released from the Eudragit S100-coated PAMs, and 51 % of the cisplatin was released from the uncoated PAMs at 1 h. The release of cisplatin from the Eudragit S100-coated PAMs was more sustained in simulated gastric fluid than in simulated intestinal fluid due to the increased solubility of the coating polymer in media with pH >7.0. Drug release from the Eudragit S100-coated PAMs was best described by the Higuchi’s square root model. From these results, it was concluded that Eudragit S100-coated PAMs are a potential carrier for delivery of cisplatin to the colon.


Alginate Drug Release Pectin Dissolution Medium Simulated Gastric Fluid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Zhang L, Cao F, Ding B, Li Q, Xi Y, Zhai G. Eudragit® S100 coated calcium pectinate microspheres of curcumin for colon targeting. J Microencapsul. 2011;28:659–67.CrossRefGoogle Scholar
  2. 2.
    Pruefer FG, Lizarraga F, Maldonado V, Melendez-Zajgla J. Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells. J Chemother. 2008;20:348–54.Google Scholar
  3. 3.
    Urien S, Brain E, Bugat R, Pivot X, Lochon I, Van ML, Vauzelle F, Lokiec F. Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients. Cancer Chemother Pharmacol. 2005;55:55–60.CrossRefGoogle Scholar
  4. 4.
    Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci. 2003;6:33–66.Google Scholar
  5. 5.
    Vaidya A, Jain A, Khare P, Agrawal RK, Jain SK. Metronidazole loaded pectin microspheres for colon targeting. J Pharm Sci. 2009;98:4229–36.CrossRefGoogle Scholar
  6. 6.
    Philip AK, Philip B. Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J. 2010;25:79–87.CrossRefGoogle Scholar
  7. 7.
    Tsai SW, Chen CC, Liou HM, Hsu FY. Preparation and characterization of microspheres comprised of collagen, chondroitin sulfate, and apatite as carriers for the osteoblast-like cell MG63. J Biomed Mater Res A. 2010;93:115–22.Google Scholar
  8. 8.
    Salyers AA, Vercellotti JR, West SE, Wilkins TD. Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl Environ Microbiol. 1977;33:319–22.Google Scholar
  9. 9.
    Shah N, Shah T, Amin A. Polysaccharides: a targeting strategy for colonic drug delivery. Expert Opin Drug Deliv. 2011;8:779–96.CrossRefGoogle Scholar
  10. 10.
    Ribeiro AJ, Silva C, Ferreira D, Veiga F. Chitosan-reinforced alginate microspheres obtained through the emulsification/internal gelation technique. Eur J Pharm Sci. 2005;25:31–40.CrossRefGoogle Scholar
  11. 11.
    Kushwaha P, Fareed S, Nanda S, Mishra A. Design & fabrication of tramadol HCl loaded multiparticulate colon targeted drug delivery system. J Chem Pharm Res. 2011;3:584–95.Google Scholar
  12. 12.
    Khan MZ, Prebeg Z, Kurjaković N. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation of drug release using Eudragit L100-55 and Eudragit S100 combinations. J Control Release. 1999;58:215–22.CrossRefGoogle Scholar
  13. 13.
    Vaidya A, Jain A, Khare P, Agrawal RK, Jain SK. Metronidazole loaded pectin microspheres for colon targeting. J Pharm Sci. 2009;98:4229–36.CrossRefGoogle Scholar
  14. 14.
    Rahman Z, Kohli K, Khar RK, Ali M, Charoo NA, Shamsher AA. Characterization of 5-fluorouracil microspheres for colonic delivery. AAPS PharmSciTech. 2006;7:E47.CrossRefGoogle Scholar
  15. 15.
    Golla ED, Ayres GH. Spectrophotometric determination of platinum with o-phenylenediamine. Talanta. 1973;20:199–210.CrossRefGoogle Scholar
  16. 16.
    Obeidat WM, Price JC. Preparation and evaluation of Eudragit S100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method. J Microencapsul. 2006;23:195–202.CrossRefGoogle Scholar
  17. 17.
    Rawat M, Saraf S, Saraf S. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres. AAPS PharmSciTech. 2007;8:E116.CrossRefGoogle Scholar
  18. 18.
    Perumal D. Microencapsulation of ibuprofen and Eudragit RS 100 by the emulsion solvent diffusion technique. Int J Pharm. 2001;218:1–11.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of Life SciencesNational Taiwan Ocean UniversityKeelungTaiwan, ROC
  2. 2.Institute of Bioscience and Biotechnology, National Taiwan Ocean UniversityKeelungTaiwan, ROC

Personalised recommendations